Bellevue Asset Management (Switzerland)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.26M Sell
2015
Q3
$2.57M Sell
2015
Q2
$6.47M Sell
2015
Q1
$6.68M Buy